Carbapenem-resistant Enterobacterales in Europe: strengthening AMR resilience through coordinated system-level action - lessons from Ukraine.

IF 5.2 2区 医学 Q1 INFECTIOUS DISEASES
Luise Martin, Arina Zanuzdana, Martin Weber, Nataliia Aliieva, Liliia Mykhajliv, Maryana Svirchuk, Mariia Boiko, Artem Horbachevskyi, Hailie Uren, Brar Christian Piening, Beate Kampmann, Tim Eckmanns, Joachim Seybold, Miriam Songa Stegemann
{"title":"Carbapenem-resistant Enterobacterales in Europe: strengthening AMR resilience through coordinated system-level action - lessons from Ukraine.","authors":"Luise Martin, Arina Zanuzdana, Martin Weber, Nataliia Aliieva, Liliia Mykhajliv, Maryana Svirchuk, Mariia Boiko, Artem Horbachevskyi, Hailie Uren, Brar Christian Piening, Beate Kampmann, Tim Eckmanns, Joachim Seybold, Miriam Songa Stegemann","doi":"10.1186/s13756-026-01834-4","DOIUrl":null,"url":null,"abstract":"<p><p>Carbapenem-resistant Enterobacterales (CRE) have emerged as one of the most serious antimicrobial resistance (AMR) threats in Europe. Rising incidence, substantial mortality, and marked heterogeneity across the EU/EEA pose a growing challenge. In Ukraine, an already substantial AMR burden and pre-existing limitations in diagnostic and infection prevention capacity, infectious diseases and antimicrobial stewardship (AMS) expertise, workforce resources, and access to effective antimicrobials have been further exacerbated by the war, including through damage to healthcare infrastructure and disruption of supply chains. These conditions facilitate the emergence and spread of CRE. As patient movement across Europe continues, CRE in Ukraine has become a shared European health security challenge. Although numerous national and international initiatives support AMR control in Ukraine, their impact is limited by fragmented implementation, insufficient coordination, and limited visibility across stakeholders. Drawing on hospital partnerships, multidisciplinary expert discussions, and emerging national coordination efforts in Ukraine, we argue that sustainable CRE control requires an integrated, system-level framework combining strengthened microbiological diagnostics and surveillance, infection prevention and control, infectious diseases and AMS expertise, and equitable access to effective antimicrobials. These components should be embedded within a coordinated national framework that aligns international support with national priorities. We describe the recently established, Ukrainian-led Public Health Center of the Ministry of Health of Ukraine (PHC) AMR Coordination Working Group as an emerging example, combining regular technical engagement, structured stakeholder collaboration, and plans to map international AMR-related activities in Ukraine. This approach may inform future European efforts to organise international AMR support in other high-burden and crisis-affected settings.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":"15 1","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13632363/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Resistance and Infection Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13756-026-01834-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Carbapenem-resistant Enterobacterales (CRE) have emerged as one of the most serious antimicrobial resistance (AMR) threats in Europe. Rising incidence, substantial mortality, and marked heterogeneity across the EU/EEA pose a growing challenge. In Ukraine, an already substantial AMR burden and pre-existing limitations in diagnostic and infection prevention capacity, infectious diseases and antimicrobial stewardship (AMS) expertise, workforce resources, and access to effective antimicrobials have been further exacerbated by the war, including through damage to healthcare infrastructure and disruption of supply chains. These conditions facilitate the emergence and spread of CRE. As patient movement across Europe continues, CRE in Ukraine has become a shared European health security challenge. Although numerous national and international initiatives support AMR control in Ukraine, their impact is limited by fragmented implementation, insufficient coordination, and limited visibility across stakeholders. Drawing on hospital partnerships, multidisciplinary expert discussions, and emerging national coordination efforts in Ukraine, we argue that sustainable CRE control requires an integrated, system-level framework combining strengthened microbiological diagnostics and surveillance, infection prevention and control, infectious diseases and AMS expertise, and equitable access to effective antimicrobials. These components should be embedded within a coordinated national framework that aligns international support with national priorities. We describe the recently established, Ukrainian-led Public Health Center of the Ministry of Health of Ukraine (PHC) AMR Coordination Working Group as an emerging example, combining regular technical engagement, structured stakeholder collaboration, and plans to map international AMR-related activities in Ukraine. This approach may inform future European efforts to organise international AMR support in other high-burden and crisis-affected settings.

欧洲耐碳青霉烯肠杆菌:通过协调一致的系统级行动加强抗菌素耐药性——来自乌克兰的经验教训。
耐碳青霉烯肠杆菌(CRE)已成为欧洲最严重的抗菌素耐药性(AMR)威胁之一。在欧盟/欧洲经济区,发病率上升、死亡率高以及明显的异质性构成了越来越大的挑战。在乌克兰,本已沉重的抗微生物药物耐药性负担以及在诊断和预防感染能力、传染病和抗微生物药物管理(AMS)专业知识、劳动力资源和获得有效抗微生物药物方面存在的限制因战争而进一步加剧,包括医疗基础设施遭到破坏和供应链中断。这些条件促进了CRE的出现和传播。随着患者在欧洲各地流动的继续,乌克兰的CRE已成为欧洲共同的卫生安全挑战。尽管有许多国家和国际倡议支持乌克兰的抗微生物药物耐药性控制,但由于实施分散、协调不足以及利益攸关方之间的可见度有限,这些倡议的影响有限。根据医院伙伴关系、多学科专家讨论和乌克兰新兴的国家协调努力,我们认为,可持续的CRE控制需要一个综合的系统级框架,结合加强的微生物诊断和监测、感染预防和控制、传染病和辅助医疗系统的专业知识,以及公平获得有效的抗菌剂。这些组成部分应纳入协调一致的国家框架,使国际支持与国家优先事项保持一致。我们将最近成立的乌克兰领导的乌克兰卫生部(PHC)抗微生物药物耐药性协调工作组公共卫生中心描述为一个新兴的例子,它结合了定期的技术参与、有组织的利益攸关方合作以及规划乌克兰抗微生物药物耐药性国际相关活动的计划。这种方法可能为欧洲未来在其他高负担和受危机影响的环境中组织国际抗微生物药物耐药性支持的努力提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.60%
发文量
140
审稿时长
13 weeks
期刊介绍: Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. The journal covers a broad spectrum of preeminent practices and best available data to the top interventional and translational research, and innovative developments in the field of infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书